Epilepsy is the most common nervous system disorder of dogs, affecting up to 0.75% of the canine population. Approximately one-third of dogs with epilepsy fail to achieve adequate seizure control with anti-seizure medication. This study aims to evaluate the role of certain intestinal bacteria in the management of epilepsy in dogs. Alterations
The Identification of Genetic Risk Factors for Canine Epilepsy
Epilepsy is one of the most common neurologic diseases of dogs and a top concern of dog breeders. Despite strong evidence that genetics is important in determining the risk of idiopathic epilepsy, numerous gene mapping studies have failed to identify a locus that accounts for that risk in either dogs or humans. Seizures occur when
Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy
Epilepsy is the most common neurologic condition in dogs. Approximately 20-30% of dogs receiving standard therapy remain uncontrolled for their seizures. Additionally, the side effects of the antiepileptic drugs (AED) are often unacceptable. Thus, there is a need for an AED that is efficacious with minimal side effects. Cannabidiol
Identification of a Novel Juvenile Myoclonic Epilepsy Gene and Its Underlying Disease Mechanism
Epilepsy is the most common neurological disease in dogs and affects almost all breeds. Genetics is likely to play a major role in seizure risk, and gene discovery remains as an important goal to better understand the disease and its treatment.
Investigating a Ketogenic Medium-Chain Triglyceride (MCT) Supplement for the Treatment of Drug-Resistant Canine Idiopathic Epilepsy and Its Behavioral Comorbidities
Canine epilepsy is a chronic neurological condition, often requiring lifelong medication with anti-epileptic drugs (AEDs). Despite appropriate treatment with available AEDs, seizure freedom may not always be achievable.
Identification of Genetic Risk Factors for Canine Epilepsy
Epilepsy is one of the most common neurologic diseases of dogs and a top concern of dog breeders. In spite of strong evidence that genetics is important in determining the risk of the common idiopathic epilepsy, numerous gene mapping studies have failed to identify a locus that accounts for that risk in either dogs or humans.
Canine Epilepsy: Genetic Variants, Biomarkers, and New Therapies
Epilepsy is a significant seizure disorder affecting all dog breeds. It is the most common chronic nervous system disorder in dogs, with a prevalence of 0.5% – 5.7%, resulting in approximately 2 million affected dogs in the USA.
Neurostimulation: A Groundbreaking New Treatment for Canine Epilepsy
Epilepsy is a debilitating condition that affects a large number of dogs, resulting in premature death and distress for their owners. For many dogs the underlying cause is unknown.